Subsequent Event	9 Months Ended
Jun. 27, 2014
Subsequent Event	19. SUBSEQUENT EVENT In July 2014, the Company closed the acquisition of certain assets and liabilities of Transpire, Inc., a privately-held developer of software solutions for accurately and rapidly predicting the macroscopic behavior of radiation. The transaction will be accounted for as a business combination. The total purchase consideration for the acquisition is $16 million in cash, excluding potential earn-out consideration of up to $4 million, which will be paid over the next three years if certain performance targets are achieved. The Company is currently evaluating the purchase price allocation for this transaction.

Subsequent Event

9 Months Ended

Jun. 27, 2014

19. SUBSEQUENT EVENT

In July 2014, the Company closed the acquisition of certain assets and liabilities of Transpire, Inc., a privately-held developer of software solutions for accurately and rapidly predicting the macroscopic behavior of radiation. The transaction will be accounted for as a business combination. The total purchase consideration for the acquisition is $16 million in cash, excluding potential earn-out consideration of up to $4 million, which will be paid over the next three years if certain performance targets are achieved. The Company is currently evaluating the purchase price allocation for this transaction.